3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
32
Gastro-enteropancreatic neuroendocrine tumor
6
Carcinoid Tumor
4
Adenoma, Islet Cell
3
Serotonin Syndrome
2
Parkinson Disease
2
Neuroblastoma
2
Neoplasms
2
Congenital Hyperinsulinism
2
Advanced Gastroenteropancreatic Neuroendocrine Tumor
2
Thymus Neoplasms
1
Pancreatic Neuroendocrine Tumors in MEN1
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Non functioning pancreatic endocrine tumor
1
Neuroendocrine Tumors in Lung
1
Neuroectodermal Tumors, Primitive
1
Neoplasm Metastasis
1
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
1
Lymphoma, Follicular
1
Liposarcoma
1
Lewy Body Disease
1
Insulinoma
1
Hypoglycemia
1
Hyperinsulinism
1
Flushing
1
Fibrosarcoma
1
Disease
1
Digestive Neuroendocrine Tumors
1
Diarrhea
1
Carcinoid Tumors, Intestinal
1
Interventions
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Thymus Neoplasms
×
NET
×
Clear all
NCT05918302
2026-05-12
LEVEL
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
Recruiting
170 enrolled